SHSAXETF / FundBlackRock Health Sciences Opportunities Portfolio
Verdicts genuinely change. Free email alert the moment SHSAX's does — no target price to set, unlike "Alert" above.
Whether this fund clears the published standards, and the filings behind that answer. The screen runs first and nothing on the trading side can override it.
Structure, momentum, positioning and levels. Separate from the Sharia verdict above, which this side never overrides.
BlackRock Health Sciences Opportunities Portfolio · BlackRock Funds
137 holdings
This fund holds short positions, so exposure is counted gross — long and short both count as exposure rather than netting off, and the weights below therefore sum to 101% of net assets rather than 100%. Shares of the portfolio are shown as shares of that gross exposure.
NON-COMPLIANT 19.65% of portfolio weight is in non-compliant holdings, over the 5% threshold.
137 holdings, 83 matched (89% of weight). Portfolio as of 2026-08-31, filed 2026-10-26. Source: SEC Form N-PORT.
2.24% of this portfolio’s income is non-permissible — weighted across holdings, computed over 81% of portfolio weight (69 of 137 holdings). The common approach purifies that proportion of income received — dividends — not of the position’s value. We report the ratio; what to do with it is a question for your own scholar.
69.8% compliant 0.0% questionable 19.5% non-compliant 10.7% unscreened
All holdings (137)
| Holding | Status | Weight | Every methodology, and the debt ratio behind it |
|---|---|---|---|
| LLY ELI LILLY & COMPANY | COMPLIANT | 11.92% | AAOIFI5.2% Usmani38.6% Dow Jones Islamic6.4% S&P Shariah6.9% MSCI Islamic38.6% MSCI Islamic M-Series6.9% FTSE Shariah38.6% |
| JNJ JOHNSON & JOHNSON | COMPLIANT | 8.03% | AAOIFI7.6% Usmani24.4% Dow Jones Islamic10.9% S&P Shariah11.7% MSCI Islamic24.4% MSCI Islamic M-Series11.7% FTSE Shariah24.4% |
| MRK MERCK & COMPANY INC | COMPLIANT | 5.56% | AAOIFI14.7% Usmani41.5% Dow Jones Islamic21.8% S&P Shariah20.9% MSCI Islamic41.5% MSCI Islamic M-Series20.9% FTSE Shariah41.5% |
| ABBV ABBVIE INC | COMPLIANT | 5.07% | AAOIFIpass Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriespass FTSE Shariahfail |
| TMO THERMO FISHER SCIENTIFIC INC | COMPLIANT | 4.41% | AAOIFI20.5% Usmani40.3% Dow Jones Islamic23.4% S&P Shariah22.9% MSCI Islamic40.3% MSCI Islamic M-Series22.9% FTSE Shariah40.3% |
| UNH UNITEDHEALTH GROUP INC | NON_COMPLIANT | 4.33% | AAOIFI20.4% Usmani23.7% Dow Jones Islamic20.4% S&P Shariah18.8% MSCI Islamic23.7% MSCI Islamic M-Series18.8% FTSE Shariah23.7% |
| GILD GILEAD SCIENCES INC | COMPLIANT | 4.09% | AAOIFI14.4% Usmani53.2% Dow Jones Islamic18.6% S&P Shariah21.4% MSCI Islamic53.2% MSCI Islamic M-Series21.4% FTSE Shariah53.2% |
| AMGN AMGEN INC | COMPLIANT | 3.98% | AAOIFI24.9% Usmani59.9% Dow Jones Islamic33.6% S&P Shariah35.1% MSCI Islamic59.9% MSCI Islamic M-Series35.1% FTSE Shariah59.9% |
| VRTX VERTEX PHARMACEUTICALS INC | COMPLIANT | 3.33% | AAOIFI1.6% Usmani7.2% Dow Jones Islamic1.7% S&P Shariah1.7% MSCI Islamic7.2% MSCI Islamic M-Series1.7% FTSE Shariah0.0% |
| ABT ABBOTT LABORATORIES | COMPLIANT | 2.74% | AAOIFI19.2% Usmani31.9% Dow Jones Islamic17.6% S&P Shariah18.3% MSCI Islamic31.9% MSCI Islamic M-Series18.3% FTSE Shariah30.8% |
| PFE PFIZER INC | NON_COMPLIANT | 2.40% | AAOIFI39.8% Usmani31.4% Dow Jones Islamic46.1% S&P Shariah45.9% MSCI Islamic31.4% MSCI Islamic M-Series45.9% FTSE Shariah31.4% |
| DHR DANAHER CORP | COMPLIANT | 2.29% | AAOIFI18.2% Usmani28.8% Dow Jones Islamic17.7% S&P Shariah16.7% MSCI Islamic28.8% MSCI Islamic M-Series16.7% FTSE Shariah28.8% |
| EW EDWARDS LIFESCIENCES CORP | COMPLIANT | 2.27% | AAOIFI1.4% Usmani5.1% Dow Jones Islamic1.5% S&P Shariah1.5% MSCI Islamic5.1% MSCI Islamic M-Series1.5% FTSE Shariah4.3% |
| ELV ELEVANCE HEALTH INC | NON_COMPLIANT | 1.86% | AAOIFI35.1% Usmani24.6% Dow Jones Islamic37.4% S&P Shariah33.5% MSCI Islamic24.6% MSCI Islamic M-Series33.5% FTSE Shariah24.6% |
| SYK STRYKER CORP | COMPLIANT | 1.80% | AAOIFI14.6% Usmani32.2% Dow Jones Islamic11.3% S&P Shariah11.8% MSCI Islamic32.2% MSCI Islamic M-Series11.8% FTSE Shariah31.2% |
| BMY BRISTOL-MYERS SQUIBB COMPANY | NON_COMPLIANT | 1.77% | AAOIFI37.3% Usmani51.1% Dow Jones Islamic42.2% S&P Shariah44.8% MSCI Islamic51.1% MSCI Islamic M-Series44.8% FTSE Shariah48.9% |
| ARGX ARGENX SE | COMPLIANT | 1.54% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| BIIB BIOGEN INC | COMPLIANT | 1.24% | AAOIFI21.2% Usmani22.5% Dow Jones Islamic27.5% S&P Shariah24.3% MSCI Islamic22.5% MSCI Islamic M-Series24.3% FTSE Shariah21.3% |
| TEVA PHARMACEUTICAL INDUSTRIES LTD | UNSCREENED | 1.21% | no in-house ratios for this holding |
| BLACKROCK FUNDS III | UNSCREENED | 1.17% | no in-house ratios for this holding |
| REVOLUTION MEDICINES INC | UNSCREENED | 1.17% | no in-house ratios for this holding |
| WAT WATERS CORP | COMPLIANT | 1.13% | AAOIFI14.1% Usmani21.2% Dow Jones Islamic21.2% S&P Shariah23.3% MSCI Islamic21.2% MSCI Islamic M-Series23.3% FTSE Shariah19.7% |
| IQV IQVIA HOLDINGS INC | NON_COMPLIANT | 1.08% | AAOIFI36.7% Usmani55.2% Dow Jones Islamic47.8% S&P Shariah44.8% MSCI Islamic54.4% MSCI Islamic M-Series44.8% FTSE Shariah53.4% |
| MRNA MODERNA INC | NON_COMPLIANT | 0.98% | AAOIFI2.2% Usmani11.7% Dow Jones Islamic7.4% S&P Shariah5.1% MSCI Islamic11.4% MSCI Islamic M-Series5.1% FTSE Shariah5.4% |
| ILMN ILLUMINA INC | COMPLIANT | 0.95% | AAOIFI1.6% Usmani8.1% Dow Jones Islamic2.7% S&P Shariah2.7% MSCI Islamic8.1% MSCI Islamic M-Series2.7% FTSE Shariah0.0% |
| DXCM DEXCOM INC | COMPLIANT | 0.95% | AAOIFI4.1% Usmani21.7% Dow Jones Islamic4.7% S&P Shariah4.0% MSCI Islamic20.9% MSCI Islamic M-Series4.0% FTSE Shariah19.3% |
| BSX BOSTON SCIENTIFIC CORP | COMPLIANT | 0.94% | AAOIFI19.4% Usmani27.9% Dow Jones Islamic10.0% S&P Shariah10.9% MSCI Islamic27.9% MSCI Islamic M-Series10.9% FTSE Shariah27.9% |
| HCA HCA HEALTHCARE INC | NON_COMPLIANT | 0.90% | AAOIFI57.2% Usmani82.9% Dow Jones Islamic53.5% S&P Shariah56.7% MSCI Islamic81.7% MSCI Islamic M-Series56.7% FTSE Shariah78.1% |
| INCY INCYTE CORP | COMPLIANT | 0.85% | AAOIFI0.1% Usmani0.7% Dow Jones Islamic0.1% S&P Shariah0.1% MSCI Islamic0.3% MSCI Islamic M-Series0.1% FTSE Shariah0.0% |
| PTGX PROTAGONIST THERAPEUTICS INC | NON_COMPLIANT | 0.76% | AAOIFI0.1% Usmani1.0% Dow Jones Islamic0.2% S&P Shariah0.3% MSCI Islamic1.0% MSCI Islamic M-Series0.3% FTSE Shariah0.0% |
| CYTK CYTOKINETICS INC | NON_COMPLIANT | 0.72% | AAOIFI3.9% Usmani20.7% Dow Jones Islamic5.9% S&P Shariah6.2% MSCI Islamic20.7% MSCI Islamic M-Series6.2% FTSE Shariah14.3% |
| PEN PENUMBRA INC | COMPLIANT | 0.68% | AAOIFI1.5% Usmani10.8% Dow Jones Islamic1.7% S&P Shariah1.9% MSCI Islamic9.7% MSCI Islamic M-Series1.9% FTSE Shariah0.0% |
| A AGILENT TECHNOLOGIES INC | COMPLIANT | 0.65% | AAOIFI9.3% Usmani28.3% Dow Jones Islamic10.8% S&P Shariah10.7% MSCI Islamic28.3% MSCI Islamic M-Series10.7% FTSE Shariah28.3% |
| THC TENET HEALTHCARE CORP | NON_COMPLIANT | 0.64% | AAOIFI63.5% Usmani43.2% Dow Jones Islamic83.2% S&P Shariah95.3% MSCI Islamic43.2% MSCI Islamic M-Series95.3% FTSE Shariah43.2% |
| GALDY GALDERMA GROUP AG | COMPLIANT | 0.61% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| COR CENCORA INC | COMPLIANT | 0.61% | AAOIFI18.9% Usmani14.0% Dow Jones Islamic20.8% S&P Shariah22.7% MSCI Islamic14.0% MSCI Islamic M-Series22.7% FTSE Shariah14.0% |
| BLACKROCK LIQUIDITY FUNDS | UNSCREENED | 0.58% | no in-house ratios for this holding |
| INSMED INC | UNSCREENED | 0.57% | no in-house ratios for this holding |
| COGENT BIOSCIENCES INC | UNSCREENED | 0.57% | no in-house ratios for this holding |
| APOGEE THERAPEUTICS INC | UNSCREENED | 0.56% | no in-house ratios for this holding |
| NVS NOVARTIS AG | COMPLIANT | 0.50% | AAOIFI12.5% Usmani25.9% Dow Jones Islamic11.8% S&P Shariah12.6% MSCI Islamic25.9% MSCI Islamic M-Series12.6% FTSE Shariah25.9% |
| HUM HUMANA INC | NON_COMPLIANT | 0.45% | AAOIFI30.1% Usmani26.3% Dow Jones Islamic44.9% S&P Shariah38.8% MSCI Islamic26.3% MSCI Islamic M-Series38.8% FTSE Shariah25.3% |
| UTHR UNITED THERAPEUTICS CORP | NON_COMPLIANT | 0.45% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| LB PHARMACEUTICALS INC | UNSCREENED | 0.42% | no in-house ratios for this holding |
| HALO HALOZYME THERAPEUTICS INC | COMPLIANT | 0.41% | AAOIFI17.2% Usmani83.3% Dow Jones Islamic27.4% S&P Shariah30.4% MSCI Islamic83.3% MSCI Islamic M-Series30.4% FTSE Shariah83.3% |
| TEM TEMPUS AI INC | COMPLIANT | 0.41% | AAOIFI0.7% Usmani3.5% Dow Jones Islamic0.8% S&P Shariahpass MSCI Islamic3.5% MSCI Islamic M-Seriespass FTSE Shariah0.0% |
| CVS CVS HEALTH CORP | NON_COMPLIANT | 0.39% | AAOIFI61.7% Usmani30.1% Dow Jones Islamic84.9% S&P Shariah88.7% MSCI Islamic30.1% MSCI Islamic M-Series88.7% FTSE Shariah24.2% |
| ORUKA THERAPEUTICS INC | UNSCREENED | 0.38% | no in-house ratios for this holding |
| MCK MCKESSON CORP | COMPLIANT | 0.38% | AAOIFI12.5% Usmani14.9% Dow Jones Islamic14.5% S&P Shariah15.8% MSCI Islamic14.7% MSCI Islamic M-Series15.8% FTSE Shariah12.5% |
| BRKR BRUKER CORP | COMPLIANT | 0.36% | AAOIFI19.3% Usmani30.1% Dow Jones Islamic25.8% S&P Shariah22.6% MSCI Islamic30.1% MSCI Islamic M-Series22.6% FTSE Shariah30.1% |
| ERASCA INC | UNSCREENED | 0.35% | no in-house ratios for this holding |
| RYTM RHYTHM PHARMACEUTICALS INC | NON_COMPLIANT | 0.33% | AAOIFI1.8% Usmani25.1% Dow Jones Islamic2.0% S&P Shariah2.4% MSCI Islamic25.1% MSCI Islamic M-Series2.4% FTSE Shariah24.3% |
| BMRN BIOMARIN PHARMACEUTICAL INC | NON_COMPLIANT | 0.33% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| ROIVANT SCIENCES LTD | UNSCREENED | 0.33% | no in-house ratios for this holding |
| MTD METTLER-TOLEDO INTERNATIONAL INC | COMPLIANT | 0.33% | AAOIFI7.8% Usmani57.5% Dow Jones Islamic8.0% S&P Shariah7.9% MSCI Islamic57.5% MSCI Islamic M-Series7.9% FTSE Shariah57.5% |
| MBX BIOSCIENCES INC | UNSCREENED | 0.32% | no in-house ratios for this holding |
| DGX QUEST DIAGNOSTICS INC | COMPLIANT | 0.32% | AAOIFI24.4% Usmani37.7% Dow Jones Islamic32.1% S&P Shariah35.4% MSCI Islamic37.7% MSCI Islamic M-Series35.4% FTSE Shariah33.3% |
| DIANTHUS THERAPEUTICS INC | UNSCREENED | 0.31% | no in-house ratios for this holding |
| NBIX NEUROCRINE BIOSCIENCES INC | COMPLIANT | 0.27% | AAOIFI2.9% Usmani8.6% Dow Jones Islamic3.4% S&P Shariah3.5% MSCI Islamic8.6% MSCI Islamic M-Series3.5% FTSE Shariah0.0% |
| AXSM AXSOME THERAPEUTICS INC | COMPLIANT | 0.27% | AAOIFI1.9% Usmani29.5% Dow Jones Islamic2.9% S&P Shariah3.5% MSCI Islamic27.6% MSCI Islamic M-Series3.5% FTSE Shariah24.7% |
| RCUS ARCUS BIOSCIENCES INC | COMPLIANT | 0.26% | AAOIFI4.0% Usmani12.3% Dow Jones Islamic5.6% S&P Shariah6.2% MSCI Islamic12.3% MSCI Islamic M-Series6.2% FTSE Shariah10.9% |
| CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC | COMPLIANT | 0.25% | AAOIFI21.2% Usmani40.3% Dow Jones Islamic33.1% S&P Shariah30.9% MSCI Islamic40.3% MSCI Islamic M-Series30.9% FTSE Shariah34.9% |
| MDGL MADRIGAL PHARMACEUTICALS INC | COMPLIANT | 0.23% | AAOIFI2.8% Usmani27.9% Dow Jones Islamic3.8% S&P Shariah4.6% MSCI Islamic27.9% MSCI Islamic M-Series4.6% FTSE Shariah27.4% |
| NTRA NATERA INC | COMPLIANT | 0.23% | AAOIFI0.5% Usmani9.0% Dow Jones Islamic0.9% S&P Shariah1.2% MSCI Islamic9.0% MSCI Islamic M-Series1.2% FTSE Shariah3.0% |
| STOK STOKE THERAPEUTICS INC | NON_COMPLIANT | 0.23% | AAOIFI0.1% Usmani0.7% Dow Jones Islamic0.2% S&P Shariah0.3% MSCI Islamic0.7% MSCI Islamic M-Series0.3% FTSE Shariah0.0% |
| ABCL ABCELLERA BIOLOGICS INC | NON_COMPLIANT | 0.23% | AAOIFI3.8% Usmani10.4% Dow Jones Islamic11.0% S&P Shariah11.0% MSCI Islamic10.4% MSCI Islamic M-Series11.0% FTSE Shariah0.0% |
| SCHOLAR ROCK HOLDING CORP | UNSCREENED | 0.20% | no in-house ratios for this holding |
| EXEL EXELIXIS INC | COMPLIANT | 0.20% | AAOIFI1.2% Usmani6.7% Dow Jones Islamic1.5% S&P Shariah1.7% MSCI Islamic6.7% MSCI Islamic M-Series1.7% FTSE Shariah0.0% |
| VIRIDIAN THERAPEUTICS INC | UNSCREENED | 0.19% | no in-house ratios for this holding |
| WST WEST PHARMACEUTICAL SERVICES INC | COMPLIANT | 0.17% | AAOIFI1.3% Usmani7.8% Dow Jones Islamic1.6% S&P Shariah1.4% MSCI Islamic7.7% MSCI Islamic M-Series1.4% FTSE Shariah5.0% |
| LARONDE INC | UNSCREENED | 0.17% | no in-house ratios for this holding |
| ADARX PHARMACEUTICALS INC | UNSCREENED | 0.17% | no in-house ratios for this holding |
| IONS IONIS PHARMACEUTICALS INC | NON_COMPLIANT | 0.16% | AAOIFI21.0% Usmani67.5% Dow Jones Islamic23.0% S&P Shariah25.1% MSCI Islamic67.5% MSCI Islamic M-Series25.1% FTSE Shariah58.8% |
| NVCR NOVOCURE LTD | NON_COMPLIANT | 0.16% | AAOIFI13.9% Usmani29.2% Dow Jones Islamic12.6% S&P Shariah12.9% MSCI Islamic29.2% MSCI Islamic M-Series12.9% FTSE Shariah24.5% |
| VAXCYTE INC | UNSCREENED | 0.14% | no in-house ratios for this holding |
| NTLA INTELLIA THERAPEUTICS INC | NON_COMPLIANT | 0.13% | AAOIFI4.1% Usmani8.6% Dow Jones Islamic5.1% S&P Shariah4.1% MSCI Islamic8.6% MSCI Islamic M-Series4.1% FTSE Shariah0.0% |
| RADNET INC | UNSCREENED | 0.13% | no in-house ratios for this holding |
| IMNM IMMUNOME INC | NON_COMPLIANT | 0.12% | AAOIFI0.2% Usmani0.8% Dow Jones Islamic0.3% S&P Shariah0.4% MSCI Islamic0.8% MSCI Islamic M-Series0.4% FTSE Shariah0.0% |
| BRIDGEBIO ONCOLOGY THERAPEUTICS INC | UNSCREENED | 0.12% | no in-house ratios for this holding |
| PALVELLA THERAPEUTICS INC | UNSCREENED | 0.12% | no in-house ratios for this holding |
| EIKN EIKON THERAPEUTICS INC | NON_COMPLIANT | 0.12% | AAOIFI42.9% Usmani32.4% Dow Jones Islamic— S&P Shariah— MSCI Islamic32.4% MSCI Islamic M-Series— FTSE Shariah0.0% |
| DYNE THERAPEUTICS INC | UNSCREENED | 0.11% | no in-house ratios for this holding |
| AKTIS ONCOLOGY INC | UNSCREENED | 0.11% | no in-house ratios for this holding |
| BRIGHT MINDS BIOSCIENCES INC | UNSCREENED | 0.11% | no in-house ratios for this holding |
| IMCR IMMUNOCORE HOLDINGS PLC | NON_COMPLIANT | 0.11% | AAOIFI24.8% Usmani42.8% Dow Jones Islamic29.4% S&P Shariah24.5% MSCI Islamic42.8% MSCI Islamic M-Series24.5% FTSE Shariah39.2% |
| KLRA KAILERA THERAPEUTICS INC | NON_COMPLIANT | 0.10% | AAOIFI0.5% Usmani0.8% Dow Jones Islamic— S&P Shariah— MSCI Islamic0.8% MSCI Islamic M-Series— FTSE Shariah0.0% |
| ENANTA PHARMACEUTICALS INC | UNSCREENED | 0.10% | no in-house ratios for this holding |
| Angitia Biopharmaceuticals Limited | UNSCREENED | 0.10% | no in-house ratios for this holding |
| KYMR KYMERA THERAPEUTICS INC | NON_COMPLIANT | 0.10% | AAOIFI0.8% Usmani4.8% Dow Jones Islamic1.7% S&P Shariah2.1% MSCI Islamic4.6% MSCI Islamic M-Series2.1% FTSE Shariah0.0% |
| GENESIS THERAPEUTICS INC | UNSCREENED | 0.10% | no in-house ratios for this holding |
| RELAY THERAPEUTICS INC | UNSCREENED | 0.10% | no in-house ratios for this holding |
| SGMT SAGIMET BIOSCIENCES INC | NON_COMPLIANT | 0.09% | AAOIFI0.3% Usmani0.7% Dow Jones Islamic1.0% S&P Shariah1.2% MSCI Islamic0.7% MSCI Islamic M-Series1.2% FTSE Shariah0.0% |
| DENALI THERAPEUTICS INC | UNSCREENED | 0.09% | no in-house ratios for this holding |
| AVALO THERAPEUTICS INC | UNSCREENED | 0.09% | no in-house ratios for this holding |
| INSITRO INC | UNSCREENED | 0.09% | no in-house ratios for this holding |
| BIOHAVEN LTD | UNSCREENED | 0.08% | no in-house ratios for this holding |
| KARTOS THERAPEUTICS INC | UNSCREENED | 0.08% | no in-house ratios for this holding |
| KLRA KAILERA THERAPEUTICS INC | NON_COMPLIANT | 0.08% | AAOIFI0.5% Usmani0.8% Dow Jones Islamic— S&P Shariah— MSCI Islamic0.8% MSCI Islamic M-Series— FTSE Shariah0.0% |
| BEAM BEAM THERAPEUTICS INC | NON_COMPLIANT | 0.08% | AAOIFI8.2% Usmani17.8% Dow Jones Islamic10.4% S&P Shariah10.7% MSCI Islamic17.8% MSCI Islamic M-Series10.7% FTSE Shariah7.2% |
| MAZE MAZE THERAPEUTICS INC | COMPLIANT | 0.08% | AAOIFI4.2% Usmani11.4% Dow Jones Islamicfail S&P Shariahfail MSCI Islamic11.4% MSCI Islamic M-Seriesfail FTSE Shariah7.3% |
| TNGX TANGO THERAPEUTICS INC | NON_COMPLIANT | 0.08% | AAOIFI0.7% Usmani3.0% Dow Jones Islamic1.9% S&P Shariah2.3% MSCI Islamic3.0% MSCI Islamic M-Series2.3% FTSE Shariah0.0% |
| KODIAK SCIENCES INC | UNSCREENED | 0.08% | no in-house ratios for this holding |
| GLUE MONTE ROSA THERAPEUTICS INC | NON_COMPLIANT | 0.07% | AAOIFI4.3% Usmani5.5% Dow Jones Islamic4.5% S&P Shariah5.9% MSCI Islamic5.5% MSCI Islamic M-Series5.9% FTSE Shariah0.0% |
| GPCR STRUCTURE THERAPEUTICS INC | NON_COMPLIANT | 0.07% | AAOIFI0.2% Usmani0.4% Dow Jones Islamic0.1% S&P Shariah0.1% MSCI Islamic0.4% MSCI Islamic M-Series0.1% FTSE Shariah0.0% |
| SUMMIT THERAPEUTICS INC | UNSCREENED | 0.06% | no in-house ratios for this holding |
| BICARA THERAPEUTICS INC | UNSCREENED | 0.06% | no in-house ratios for this holding |
| ZEAL.CO ZEALAND PHARMA A/S | NON_COMPLIANT | 0.05% | AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail |
| RARE ULTRAGENYX PHARMACEUTICAL INC | NON_COMPLIANT | 0.05% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| DEFINIUM THERAPEUTICS INC | UNSCREENED | 0.05% | no in-house ratios for this holding |
| BRAVEHEART BIO INC | UNSCREENED | 0.05% | no in-house ratios for this holding |
| OCUL OCULAR THERAPEUTIX INC | NON_COMPLIANT | 0.04% | AAOIFI0.3% Usmani1.0% Dow Jones Islamic0.4% S&P Shariah0.5% MSCI Islamic1.0% MSCI Islamic M-Series0.5% FTSE Shariah0.0% |
| QUANTA DIALYSIS TECHNOLOGIES LTD | UNSCREENED | 0.04% | no in-house ratios for this holding |
| VOR VOR BIOPHARMA INC | NON_COMPLIANT | 0.04% | AAOIFI0.3% Usmani0.6% Dow Jones Islamic0.9% S&P Shariah1.2% MSCI Islamic0.6% MSCI Islamic M-Series1.2% FTSE Shariah0.0% |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | NON_COMPLIANT | 0.04% | AAOIFI8.0% Usmani17.7% Dow Jones Islamic4.2% S&P Shariah3.6% MSCI Islamic17.7% MSCI Islamic M-Series3.6% FTSE Shariah17.3% |
| RGNX REGENXBIO INC | NON_COMPLIANT | 0.03% | AAOIFI11.7% Usmani17.8% Dow Jones Islamic14.0% S&P Shariah12.0% MSCI Islamic17.8% MSCI Islamic M-Series12.0% FTSE Shariah0.0% |
| FDMT 4D MOLECULAR THERAPEUTICS INC | NON_COMPLIANT | 0.03% | AAOIFI4.7% Usmani8.0% Dow Jones Islamic9.8% S&P Shariah6.8% MSCI Islamic8.0% MSCI Islamic M-Series6.8% FTSE Shariah4.0% |
| WVE WAVE LIFE SCIENCES INC | NON_COMPLIANT | 0.03% | AAOIFI3.9% Usmani7.8% Dow Jones Islamic2.9% S&P Shariah3.6% MSCI Islamic7.8% MSCI Islamic M-Series3.6% FTSE Shariah0.0% |
| CRVS CORVUS PHARMACEUTICALS INC | COMPLIANT | 0.02% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| ALLOGENE THERAPEUTICS INC | UNSCREENED | 0.02% | no in-house ratios for this holding |
| SYNDAX PHARMACEUTICALS INC | UNSCREENED | 0.02% | no in-house ratios for this holding |
| OBIO ORCHESTRA BIOMED HOLDINGS INC | NON_COMPLIANT | 0.02% | AAOIFI5.3% Usmani14.1% Dow Jones Islamic8.2% S&P Shariah7.7% MSCI Islamic14.1% MSCI Islamic M-Series7.7% FTSE Shariah13.0% |
| GOLDFINCH BIO INC | UNSCREENED | 0.01% | no in-house ratios for this holding |
| ANNX ANNEXON INC | COMPLIANT | 0.01% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| MPLT MAPLIGHT THERAPEUTICS INC | NON_COMPLIANT | 0.01% | AAOIFI0.3% Usmani0.5% Dow Jones Islamic— S&P Shariah— MSCI Islamic0.5% MSCI Islamic M-Series— FTSE Shariah0.0% |
| AFFINIVAX INC | UNSCREENED | 0.01% | no in-house ratios for this holding |
| CELLARITY INC | UNSCREENED | 0.01% | no in-house ratios for this holding |
| ABIOMED INC | UNSCREENED | 0.01% | no in-house ratios for this holding |
| EXO IMAGING INC | UNSCREENED | 0.00% | no in-house ratios for this holding |
| BLUEPRINT MEDICINES CORP | UNSCREENED | 0.00% | no in-house ratios for this holding |
| MIRATI THERAPEUTICS INC | UNSCREENED | 0.00% | no in-house ratios for this holding |
| GOSS GOSSAMER BIO INC | NON_COMPLIANT | 0.00% | AAOIFI4.6% Usmani5.1% Dow Jones Islamic1.3% S&P Shariah1.5% MSCI Islamic5.1% MSCI Islamic M-Series1.5% FTSE Shariah0.0% |
| ARCELLX INC | UNSCREENED | 0.00% | no in-house ratios for this holding |
| SWIFT HEALTH SYSTEMS INC | UNSCREENED | 0.00% | no in-house ratios for this holding |
| HOLOGIC INC | UNSCREENED | 0.00% | no in-house ratios for this holding |
| EXO IMAGING INC | UNSCREENED | 0.00% | no in-house ratios for this holding |
| FREQUENCY THERAPEUTICS CVR | UNSCREENED | 0.00% | no in-house ratios for this holding |
| GOLDFINCH EQUITY WARRANTS | UNSCREENED | 0.00% | no in-house ratios for this holding |
The published standards disagree about this fund by 39 points of portfolio weight — 69.9% of it passes AAOIFI, 30.7% passes MSCI Islamic. Which number is yours depends on which standard you follow.
These bars are the financial-ratio result under each standard — debt, receivables and interest income. They do not screen what the business does, so a holding can pass every ratio here and still be questionable or non-compliant on activity. The blended verdict above accounts for both.
ratios pass on 69.9% ratios fail on 14.3% 16.6% not rated under AAOIFI
ratios pass on 36.1% ratios fail on 47.8% 16.9% not rated under Usmani
ratios pass on 64.1% ratios fail on 19.1% 17.6% not rated under Dow Jones Islamic
ratios pass on 64.4% ratios fail on 18.7% 17.7% not rated under S&P Shariah
ratios pass on 30.7% ratios fail on 56.0% 14.1% not rated under MSCI Islamic
ratios pass on 64.4% ratios fail on 18.8% 17.6% not rated under MSCI Islamic M-Series
ratios pass on 35.9% ratios fail on 47.5% 17.5% not rated under FTSE Shariah
82 of 137 listed holdings carry our own per-methodology verdicts (90% of weight). The rest hold a provider verdict with no methodology breakdown, and are counted as rated by none. Of those, 75 (82% of weight) also carry the underlying debt ratio; the rest show a verdict without the figure behind it.
| Non-compliant holding | Weight |
|---|---|
| UNH UNITEDHEALTH GROUP INC | 4.33% |
| PFE PFIZER INC | 2.40% |
| ELV ELEVANCE HEALTH INC | 1.86% |
| BMY BRISTOL-MYERS SQUIBB COMPANY | 1.77% |
| IQV IQVIA HOLDINGS INC | 1.08% |
| MRNA MODERNA INC | 0.98% |
| HCA HCA HEALTHCARE INC | 0.90% |
| PTGX PROTAGONIST THERAPEUTICS INC | 0.76% |
| CYTK CYTOKINETICS INC | 0.72% |
| THC TENET HEALTHCARE CORP | 0.64% |
Trade setup
Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.
BlackRock Health Sciences Opportunities Portfolio (SHSAX) is currently considered not halal (non-compliant), per our own look-through to its filed holdings. See its filed holdings and the weight breakdown below for the reasoning.
Screened on its holdings, not its name
HTR reads the fund's filed holdings and screens each one, then reports the result by weight. A holding it cannot cover far enough is reported as unrated rather than counted as a pass.
| Holding | Weight | Verdict |
|---|---|---|
| LLYELI LILLY & COMPANY | 11.92% | Compliant |
| JNJJOHNSON & JOHNSON | 8.03% | Compliant |
| MRKMERCK & COMPANY INC | 5.56% | Compliant |
| ABBVABBVIE INC | 5.07% | Compliant |
| TMOTHERMO FISHER SCIENTIFIC INC | 4.41% | Compliant |
| UNHUNITEDHEALTH GROUP INC | 4.33% | Non-compliant |
| GILDGILEAD SCIENCES INC | 4.09% | Compliant |
| AMGNAMGEN INC | 3.98% | Compliant |
| VRTXVERTEX PHARMACEUTICALS INC | 3.33% | Compliant |
| ABTABBOTT LABORATORIES | 2.74% | Compliant |
Top 10 of 137 holdings, 53.5% of the fund by weight. Every holding is screened, not only these.
What holds the number back
The positions keeping this fund short of 100% compliant by weight.
- UNHnon-compliant4.33%
- PFEnon-compliant2.40%
- ELVnon-compliant1.86%
- BMYnon-compliant1.77%
- TEVA PHARMACEUTICAL INDUSTRIES LTDnot screened1.21%
- BLACKROCK FUNDS IIInot screened1.17%
What changed, and when
Verdict history for SHSAX. A verdict that never moved is recorded too, so a quiet history reads as measured rather than missing.
- 2026-09-07 No change recorded No verdict change for SHSAX has been recorded since tracking began. The scan ledger records that the compliance detectors ran, not which symbols each pass covered.
ℹ️ no compliance scan has run for 6 days - this is not a reading of today
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
This fund prices once a day, so its bars carry no intraday high or low — floor-trader pivots are not defined for it.
Price Forecast
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
Technical Summary
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
Every indicator, and what it reads
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 70.10 | SELL |
| Stochastic %K (14) | 100.00 | SELL |
| CCI (20) | 152.16 | SELL |
| Williams %R (14) | 0.00 | SELL |
| MACD (12,26,9) | 0.34 | BUY |
| ROC (10) | 5.43 | BUY |
| Momentum (10) | 3.55 | BUY |
| EMA (10) | 67.08 | BUY |
| SMA (10) | 66.97 | BUY |
| EMA (20) | 66.17 | BUY |
| SMA (20) | 65.58 | BUY |
| EMA (30) | 65.66 | BUY |
| SMA (30) | 65.22 | BUY |
| EMA (50) | 64.90 | BUY |
| SMA (50) | 65.07 | BUY |
| EMA (100) | 63.29 | BUY |
| SMA (100) | 63.18 | BUY |
| EMA (200) | 61.03 | BUY |
| SMA (200) | 60.08 | BUY |
SMC — Top Down
Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.
Before you act on this
The questions worth asking about any verdict on this page, answered plainly.
Is a fund screened on its name?
No. HTR reads the fund's filed holdings and screens each one, then reports the result by weight. A fund marketed as Islamic still gets the same look-through as any other.
What does unrated weight mean?
It is the share of the fund whose holdings HTR cannot cover far enough to rate. It is reported as unrated rather than counted as compliant, because a holding nobody screened should not look like one that passed.
Does the issuer's board make it compliant?
It matters, and it is noted, but it does not replace the look-through. The board's judgement and the holdings screen are shown separately so you can see when they agree and when they do not.
How often is this re-screened?
When the fund files new holdings, and on a rolling basis besides. The date on the verdict above is the last time this fund was actually recomputed.
Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.
Compare with
Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.
Peer screening computing — it will appear here on its own.
AI Summary
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.